(Q40808575)

23 September 2017

Antibiotic therapy in cystic fibrosis: evaluation of clinical trials (English)

1 reference

23 September 2017

0 references

Smith AL

1

1 reference

PubMed ID

3517275

23 September 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

The Journal of Pediatrics

23 September 2017

1 reference

23 September 2017

108

1 reference

23 September 2017

5 Pt 2

1 reference

23 September 2017

866-870

1 reference

Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

New objective criteria for inflammation in bronchial secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Bronchial mucus in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980759-4

10.1016/S0022-3476(86)80759-4

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

3517275